Faculty profile

Armand Keating

ResearcherMechanical EngineeringUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Armand Keating

Researcher

Mechanical Engineering

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
16 publications in the last five years, latest in 2026.
Senior (last) author on 6 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2017.
Supervised 3 trainees who won CIHR awards, most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

131

Publications

246

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Airway Regeneration Biological Scaffolds Bioreactor Decellularization In Silico Modelling Lung Recellularization Systematic Process Optimization

Latest papers

Intraperitoneal administration of NK-92 improves survival in xenografts of early and established ovarian cancer models.
PloS one · 2026 · senior author
IID 2025: Physical protein interaction data with detection types, co-purified protein sets, molecular docking, and immune cell networks.
Nucleic acids research · 2026
Mesenchymal stromal cells: an update.
Current opinion in hematology · 2025 · senior author

All 131 publications

Latest funding

Identification of XPO1 cargo and modulation by SINE compounds in diffuse large B cell lymphoma
CIHR · 2023 · Supervisor
$105,000
Advanced Bioreactors for Evaluation and Systematic Optimization of Decellularization and Recellularization of the Lung and Trachea
CIHR · 2017 · Principal investigator
$291,825
Immunotherapy of leukemic stem cells
CIHR · 2013 · Supervisor
$172,500

All 6 grants and awards

131 publications.

Intraperitoneal administration of NK-92 improves survival in xenografts of early and established ovarian cancer models.

Marcus P, Warrington J, Zhang M, Ankathatti-Munegowda M, Wang XH, Rashedi I, Keating A

PloS one2026Senior author

DOI: 10.1371/journal.pone.0347095 PMID: 42008496

IID 2025: Physical protein interaction data with detection types, co-purified protein sets, molecular docking, and immune cell networks.

Kotlyar M, Pastrello C, Abovsky M, Mizeranschi A, Keating A, Cameron LC, Chandran V, Jurisica I

Nucleic acids research2026

DOI: 10.1093/nar/gkaf1259 PMID: 41296544

Mesenchymal stromal cells: an update.

Lee OJ, Keating A

Current opinion in hematology2025Senior author

DOI: 10.1097/moh.0000000000000887 PMID: 40668265

Beyond maximum grade: tolerability of immunotherapies, cellular therapies, and targeted agents in haematological malignancies.

Bröckelmann PJ, Cliff ERS, Iacoboni G, Simon F, Horowitz MM, Keating A, Mateos MV, Mohty M, Sidana S, Song Y, Wingard JR, Thanarajasingam G

The Lancet. Haematology2025

DOI: 10.1016/s2352-3026(25)00051-1 PMID: 40447355

A molecular systems architecture of the mesenchymal stromal cell microenvironment.

Ayyadurai VAS, Deonikar P, Radhakrishnan V, Keating A

Stem cells (Dayton, Ohio)2025Senior author

DOI: 10.1093/stmcls/sxaf042 PMID: 40843515

Lentivirus‐mediated gene therapy for Fabry disease: 5‐year End‐of‐Study results from the Canadian FACTs trial

Khan A, Barber DL, McKillop WM, Rupar CA, Auray‐Blais C, Fraser G, Fowler DH, Berger A, Foley R, Keating A

Clinical and Translational Medicine202517 citations

DOI: 10.1002/ctm2.70073

Reduced-intensity conditioning in LV-mediated gene therapy for Fabry disease targeting HSPCs

Khan A, Barber DL, Foley R, Keating A, West ML, Medin JA

Molecular Therapy20251 citations

DOI: 10.1016/j.ymthe.2025.07.054

Mesenchymal stromal cells as cancer promoters.

Antoon R, Overdevest N, Saleh AH, Keating A

Oncogene2024Senior author

DOI: 10.1038/s41388-024-03183-1 PMID: 39414984

Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia.

Pereira-Martins DA, Coelho-Silva JL, Weinhäuser I, Franca-Neto PL, Silveira DR, Ortiz C, Moreira-Aguiar A, Lima MM, Koury LC, de Melo RA, Glória AB, Fagundes EM, Lino BK, Pagnano K, Bittencourt R, Nunes E, Traina F, Figueiredo-Pontes L, Keating A, Tallman MS, Ribeiro RC, Dilon R, Ganser A, Sanz MA, Berliner N, Valk P, Löwenberg B, Ottone T, Noguera NI, Voso MT, Paoloni F, Fazi P, Ammatuna E, Huls G, Schuringa JJ, Rego EM, Lucena-Araujo AR

British journal of haematology2023

DOI: 10.1111/bjh.18510 PMID: 36263593

Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.

Ai H, Chao NJ, Rizzieri DA, Huang X, Spitzer TR, Wang J, Guo M, Keating A, Krakow EF, Blaise D, Ma J, Wu D, Reagan J, Gergis U, Duarte RF, Chaudhary PM, Hu K, Yu C, Sun Q, Fuchs E, Cai B, Huang Y, Qiao J, Gottlieb D, Schultz KR, Liu M, Chen X, Chen W, Wang J, Zhang X, Li J, Huang H, Sun Z, Li F, Yang L, Zhang L, Li L, Liu K, Jin J, Liu Q, Liu D, Gao C, Fan C, Wei L, Zhang X, Hu L, Zhang W, Tian Y, Han W, Zhu J, Xiao Z, Zhou D, Zhang B, Jia Y, Zhang Y, Wu X, Shen X, Lu X, Zhan X, Sun X, Xiao Y, Wang J, Shi X, Zheng B, Chen J, Ding B, Wang Z, Zhou F, Zhang M, Zhang Y, Sun J, Xia B, Chen B, Ma L

Heliyon2023

DOI: 10.1016/j.heliyon.2023.e14924 PMID: 37089296

Identification of XPO1 cargo and modulation by SINE compounds in diffuse large B cell lymphoma

SupervisorCIHR2023Doctoral Research Award: Canada Graduate Scholarships

Principal investigators: Trkulja, Kyla L

Keywords: Cancer; Combination Therapies; Hematology; Lymphoma; Mass Spectrometry; Mechanism Of Action; Nuclear Export; Proteomics; Subcellular Fractionation

$105,000

Advanced Bioreactors for Evaluation and Systematic Optimization of Decellularization and Recellularization of the Lung and Trachea

Principal investigatorCIHR2017Collaborative Health Research Projects (NSERC partnered)

Principal investigators: Amon, Cristina; Keating, Armand; Waddell, Thomas K

Keywords: Airway Regeneration; Biological Scaffolds; Bioreactor; Decellularization; In Silico Modelling; Lung; Recellularization; Systematic Process Optimization; Tissue Engineering; Trachea

$291,825

Immunotherapy of leukemic stem cells

SupervisorCIHR2013CIHR Clinician Scientist - Phase 1

Principal investigators: Williams, Brent A

Keywords: Acute Myeloid Leukemia; Immunotherapy; Leukemic Stem Cell; Natural Killer Cell

$172,500

The FACTs Project: FAbry disease Clinical research and Therapeutics

Co-investigatorCIHR2011Emerging Team Grant: Rare Diseases - INMD Basic/Clinical

Principal investigators: Medin, Jeffrey A

Keywords: Biomarker Discovery/Validation; Cell-Mediated Gene Therapy; Fabry Disease; Hematopoietic Stem Cells; Immune Outcomes; Lentivirus Vectors; Lysosomal Storage Disorders; Pilot Clinical Trial; Safety

$2,450,000

Immunotherapy of leukemic stem cells

SupervisorCIHR2010CIHR Clinician Scientist - Phase 1

Principal investigators: Williams, Brent A

Keywords: Acute Myeloid Leukemia; Immunotherapy; Leukemic Stem Cell; Natural Killer Cell

$172,500

Targeted and controlled delivery of immunotherapies

Co-investigatorNSERC2005Collaborative Health Research Projects

Principal investigators: Shoichet, Molly

$259,975

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Armand Keating

Research

Latest papers

Latest funding

Intraperitoneal administration of NK-92 improves survival in xenografts of early and established ovarian cancer models.

IID 2025: Physical protein interaction data with detection types, co-purified protein sets, molecular docking, and immune cell networks.

Mesenchymal stromal cells: an update.

Beyond maximum grade: tolerability of immunotherapies, cellular therapies, and targeted agents in haematological malignancies.

A molecular systems architecture of the mesenchymal stromal cell microenvironment.

Lentivirus‐mediated gene therapy for Fabry disease: 5‐year End‐of‐Study results from the Canadian FACTs trial

Reduced-intensity conditioning in LV-mediated gene therapy for Fabry disease targeting HSPCs

Mesenchymal stromal cells as cancer promoters.

Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia.

Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.

Identification of XPO1 cargo and modulation by SINE compounds in diffuse large B cell lymphoma

Advanced Bioreactors for Evaluation and Systematic Optimization of Decellularization and Recellularization of the Lung and Trachea

Immunotherapy of leukemic stem cells

The FACTs Project: FAbry disease Clinical research and Therapeutics

Immunotherapy of leukemic stem cells

Targeted and controlled delivery of immunotherapies

Frequent collaborators

John Kuruvilla

Sowmya Viswanathan

Ren-Ke Li

Ronan Foley

Christiane Auray-Blais

Xiao-Yan Wen

Mark Minden

Tony Panzarella

Mary Gospodarowicz

Robert Kridel

Hong-Shuo Sun

Jeffrey Medin

Fei-Fei Liu

Jim Hu

Filio Billia

Brent Williams

Zhong-Ping Feng

Nicole Prokopishyn

Rajiv Gandhi

Jagdish Butany

Osvaldo Espin Garcia

Clement Ma

Konstantin Shestopaloff

Annette Hay

Lisa Wang

Agata Bartczak

Robert Deans

Adrian Sacher

Jonas Mattsson

Wei Wang

Linda Lee

Igor Jurisica

Mingyao Liu

David Hwang

Howard Leong-Poi

Ralph Meyer

Arthur Slutsky

Vinod Chandran

Andrew Advani

Irwin Ronald Walker